Recent advancements in the structural biology of human telomerase and their implications for improved design of cancer therapeutics

Abstract Telomerase is a specialized reverse transcriptase that synthesizes telomeric repeats at the ends of linear chromosomes. Telomerase is transiently expressed in germ and stem cells, but nearly all somatic cells silence it after differentiating. However, the vast majority of cancer cells reactivate and constitutively express telomerase to maintain replicative immortality. Because of this, telomerase has remained a promising broad-spectrum chemotherapeutic target for over 30 years. However, various challenges associated with obtaining high-resolution structural data for telomerase have limited the development of rationally designed structure-based therapeutics. Various techniques and model systems have been utilized to advance our understanding of the structural biology of telomerase. In particular, multiple high-resolution cryogenic electron microscopy (cryo-EM) structures published within the past few years have revealed new components of the telomerase complex with near atomic resolution structural models. Additionally, these structures have provided details for how telomerase is recruited to telomeres and its mechanism of telomere synthesis. With these new pieces of evidence, and the promising outlook for future refinements to our current models, the possibility of telomerase specific chemotherapeutics is becoming more tangible than ever. This review summarizes these recent advancements and outlines outstanding questions in the field.

[1]  S. Antar,et al.  Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations. , 2022, Journal of medicinal chemistry.

[2]  Z. Zhou,et al.  Structure of active human telomerase with telomere shelterin protein TPP1 , 2022, Nature.

[3]  Thi Hoang Duong Nguyen,et al.  Structural basis of human telomerase recruitment by TPP1-POT1 , 2022, Science.

[4]  D. Rhodes,et al.  Insights into POT1 structural dynamics revealed by cryo-EM , 2022, PloS one.

[5]  B. Chait,et al.  Shelterin is a dimeric complex with extensive structural heterogeneity , 2022, bioRxiv.

[6]  M. Lei,et al.  Zipper head mechanism of telomere synthesis by human telomerase , 2021, Cell Research.

[7]  Yong Chen,et al.  Distinct functions of POT1 proteins contribute to the regulation of telomerase recruitment to telomeres , 2021, Nature Communications.

[8]  B. D. Freudenthal,et al.  How DNA damage and non-canonical nucleotides alter the telomerase catalytic cycle. , 2021, DNA repair.

[9]  Oriol Vinyals,et al.  Highly accurate protein structure prediction with AlphaFold , 2021, Nature.

[10]  Meenakshi Singh,et al.  Systematic review on role of structure based drug design (SBDD) in the identification of anti-viral leads against SARS-Cov-2 , 2021, Current Research in Pharmacology and Drug Discovery.

[11]  Z. Zhou,et al.  Structures of telomerase at several steps of telomere repeat synthesis , 2021, Nature.

[12]  Rhiju Das,et al.  Structure of human telomerase holoenzyme with bound telomeric DNA , 2021, Nature.

[13]  David W. Taylor,et al.  Remdesivir is a delayed translocation inhibitor of SARS-CoV-2 replication , 2020, bioRxiv.

[14]  M. Gallagher-Jones,et al.  A structurally conserved human and Tetrahymena telomerase catalytic core , 2020, Proceedings of the National Academy of Sciences.

[15]  X. Liu,et al.  Design, synthesis and SARs of novel telomerase inhibitors based on BIBR1532. , 2020, Bioorganic chemistry.

[16]  P. Opresko,et al.  Mechanisms of nucleotide selection by telomerase , 2020, eLife.

[17]  Budhayash Gautam,et al.  Molecular Docking and Structure-Based Drug Design , 2020 .

[18]  L. Tomáška,et al.  A New View of the T-Loop Junction: Implications for Self-Primed Telomere Extension, Expansion of Disease-Related Nucleotide Repeat Blocks, and Telomere Evolution , 2019, Front. Genet..

[19]  Sangdun Choi,et al.  A Structure-Based Drug Discovery Paradigm , 2019, International journal of molecular sciences.

[20]  Jonas Boström,et al.  Deep Reinforcement Learning for Multiparameter Optimization in de novo Drug Design , 2019, J. Chem. Inf. Model..

[21]  Kit-Kay Mak,et al.  Artificial intelligence in drug development: present status and future prospects. , 2019, Drug discovery today.

[22]  Yong Chen.  The structural biology of the shelterin complex , 2018, Biological chemistry.

[23]  T. de Lange,et al.  Shelterin-Mediated Telomere Protection. , 2018, Annual review of genetics.

[24]  Russ B Altman,et al.  Machine learning in chemoinformatics and drug discovery. , 2018, Drug discovery today.

[25]  Z. Zhou,et al.  Structure of Telomerase with Telomeric DNA , 2018, Cell.

[26]  Eva Nogales,et al.  Cryo-EM structure of substrate-bound human telomerase holoenzyme , 2018, Nature.

[27]  Olexandr Isayev,et al.  Deep reinforcement learning for de novo drug design , 2017, Science Advances.

[28]  K. Collins,et al.  Telomerase Mechanism of Telomere Synthesis. , 2017, Annual review of biochemistry.

[29]  E. Skordalakes,et al.  Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532. , 2015, Structure.

[30]  D. Segal,et al.  The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres , 2015, PLoS genetics.

[31]  Leonardo L. G. Ferreira,et al.  Molecular Docking and Structure-Based Drug Design Strategies , 2015, Molecules.

[32]  T. Cech,et al.  Human telomerase: biogenesis, trafficking, recruitment, and activation , 2015, Genes & development.

[33]  T. Cech,et al.  Identification of human TERT elements necessary for telomerase recruitment to telomeres , 2014, eLife.

[34]  T. Cech,et al.  Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT , 2014, Nucleic acids research.

[35]  Xiaowei Zhuang,et al.  Super-Resolution Fluorescence Imaging of Telomeres Reveals TRF2-Dependent T-loop Formation , 2013, Cell.

[36]  Sara Sandin,et al.  Structure of Active, Dimeric Human Telomerase , 2013, Nature Structural &Molecular Biology.

[37]  Leslie A. Leinwand,et al.  The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity , 2012, Nature.

[38]  Michael D. Stone,et al.  The RNA accordion model for template positioning by telomerase RNA during telomeric DNA synthesis , 2011, Nature Structural &Molecular Biology.

[39]  A. Ferré-D’Amaré,et al.  The Box H/ACA Ribonucleoprotein Complex: Interplay of RNA and Protein Structures in Post-transcriptional RNA Modification* , 2009, The Journal of Biological Chemistry.

[40]  T. de Lange,et al.  Shelterin: the protein complex that shapes and safeguards human telomeres. , 2005, Genes & development.

[41]  John M Sedivy,et al.  Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a). , 2004, Molecular cell.

[42]  E. Blackburn,et al.  New ways not to make ends meet: telomerase, DNA damage proteins and heterochromatin , 2002, Oncogene.

[43]  J. Griffith,et al.  Mammalian Telomeres End in a Large Duplex Loop , 1999, Cell.

[44]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.

[45]  G. Morin.  The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats , 1989, Cell.

[46]  R. Moyzis,et al.  Conservation of the human telomere sequence (TTAGGG)n among vertebrates. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[47]  L. S. Cram,et al.  A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Carol W. Greider,et al.  The telomere terminal transferase of tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity , 1987, Cell.

[49]  Carol W. Greider,et al.  Identification of a specific telomere terminal transferase activity in tetrahymena extracts , 1985, Cell.

[50]  A M Olovnikov,et al.  A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. , 1973, Journal of theoretical biology.

[51]  B. Mcclintock,et al.  The Stability of Broken Ends of Chromosomes in Zea Mays. , 1941, Genetics.